Uncategorized

FDA delays decision on Orca Bio cell therapy after filing more manufacturing data

Published

on

The FDA has postponed its deadline on whether to approve Orca Bio’s T cell therapy by three months to July 6.

The agency was expected to reach a verdict by April 6, but pushed back …

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version